Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 21;14(12):e32780.
doi: 10.7759/cureus.32780. eCollection 2022 Dec.

Ototoxicity of Topical Antibiotic Ear Drops in Chronic Suppurative Otitis Media in Humans: A Review of the Literature

Affiliations
Review

Ototoxicity of Topical Antibiotic Ear Drops in Chronic Suppurative Otitis Media in Humans: A Review of the Literature

Syed Zohaib Maroof Hussain et al. Cureus. .

Abstract

An electronic search of the literature was performed for reported cases of ototoxicity associated with the use of topical antibiotic ear drops in humans. The dosage, duration, and type of ototoxic preparations involved were recorded. Due to the scant quantity of low-quality information that is currently available, there was uncertainty about the usefulness of topical antibiotics in enhancing the resolution of ear discharge in patients with chronic suppurative otitis media. However, despite this uncertainty, there are some data to show that using topical antibiotics in comparison to a placebo or in conjunction with a systemic antibiotic may be useful. Additionally, there is ambiguity regarding the relative efficacy of various kinds of antibiotics; it is impossible to say with absolute certainty whether quinolones are superior to or inferior to aminoglycosides. Although the adverse impact profiles of these two classes of chemicals varied, there are not enough data from the included trials to draw any conclusions about them. Negative effects were generally underreported.

Keywords: antibiotic ear drops; cochleotoxicity; ototopical preparations; ototoxicity; sensorineural hearing loss; vestibulotoxicity.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Similar articles

References

    1. Topical antibiotics for chronic suppurative otitis media. Brennan-Jones CG, Head K, Chong LY, Burton MJ, Schilder AG, Bhutta MF. https://doi.org/10.1002/14651858.CD013051.pub2 Cochrane Database Syst Rev. 2020;1:0. - PMC - PubMed
    1. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD. https://doi.org/10.1136/bmj.c2096 BMJ. 2010;340:0. - PubMed
    1. Critical shortage of new antibiotics in development against multidrug-resistant bacteria—time to react is now. Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, Monnet DL, Cars O. https://doi.org/10.1016/j.drup.2011.02.003. Drug Resist Updat. 2011;14:118–124. - PubMed
    1. Antibiotic resistance—the need for global solutions. Laxminarayan R, Duse A, Wattal C, et al. Lancet Infect Dis. 2013;13:1057–1098. - PubMed
    1. Intratympanic gentamicin for Meniere’s disease; a survey of current UK practice. Obholzer RJ, Wareing MJ. https://doi.org/10.1258/002221503321892299. Journal of Laryngology and Otology. 2003;117:459–461. - PubMed

LinkOut - more resources